EaglePicher Medical Power Introduces New Contego 440 mAh Lithium-ion Battery

New Contego® 440: An Implantable & Rechargeable Large-capacity, Small-footprint Cell Utilizing a Proven Chemistry that Has Extensive Cycling Data Across Multiple Medical Customers

EaglePicher® Medical Power, a division of EaglerPicher Technologies, announced today the launch of the all-new Contego® 440 mAh battery, an implantable grade, lightweight, and high-energy-density lithium-ion battery.

According to EaglePicher, the rechargeable off-the-shelf Contego 440 offers superior rate capability and cycle life and is manufactured in a certified ISO13405 facility.

The Contego 440 battery comes in a fully welded hermetically sealed stainless-steel case and can be used across a range of medical applications including neuromodulators, drug pumps, body fluid pumps, and cardiac monitors. The individual battery weighs just 19.1g and carries a voltage range of 3.0 to 4.1V. While the Contego 440 is available off-the-shelf, additional options include custom terminations, application-specific documentation for FDA submission, application-specific testing, custom markings, and custom packaging.

“We’re extremely pleased to introduce the Contego 440 as part of our growing line of mission-critical medical device batteries,” commented Chris Huntington, EaglePicher Medical Power’s President. “The team at EaglePicher Medical Power is committed to developing the latest technology innovations to fuel medical advancement, treatment protocols and improve quality of life. With the new Contego 440, we’ve succeeded in delivering more energy in a small, lightweight cell, while never compromising safety.”

EaglePicher has been at the forefront of implantable medical-grade power solutions for over 25 years. The electrochemistry used in Contego lithium-ion batteries, since 2004, is proven in multiple cell sizes and is remarkably robust, without experiencing a single field failure. Over time, demand has grown for batteries like the new Contego 440, which can do more with less of a physical footprint.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version